Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.1.87 extracted from

  • Deriy, L.; Ogawa, H.; Gao, G.P.; Galili, U.
    In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene (2005), Cancer Gene Ther., 12, 528-539.
    View publication on PubMed

Application

Application Comment Organism
medicine protection against tumors by immunization with AdaGT-transduced tumor cells (replication deficient adenovirus containing the alpha1,3GT gene) is studied in alpha1,3GT knockout (KO) mice, challenged with the highly tumorigenic BL6 melanoma cells. These mice lack alpha-gal epitopes and can produce anti-Gal. Immunization of KO mice with AdaGT-transduced BL6 cells protects many of the mice against challenge with live BL6 cells lacking alpha-gal epitopes. Immunization with AdalphaGT transduced autologous tumor cells may serve as adjuvant immunotherapy delivered after completion of standard therapy Mus musculus

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-

Synonyms

Synonyms Comment Organism
alpha1,3galactosyltransferase
-
Mus musculus
alpha1,3GT
-
Mus musculus